EV
Evelo Biosciences, Inc.
EVLO · OTC
$0.00 +0.00% (+$0.00)
1M -99.00%
Market Cap $1.90K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 201.37%
Asset turnover 0.00x
ROA 177.72%
Debt
71 /100
Low Current ratio 4.16x
Net debt/EBITDA -0.03x
Int. coverage -23.31x
Stability
54 /100
Moderate Beta 1.31x
Profitable years 0
EPS volatility 21.29%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EVLO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
66
Headquarters
Cambridge
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report